4
Changes in Ownership
Contineum Therapeutics, Inc. Filed Acc 0001437749-26-006422
Chief Scientific Officer sold 4,170 shares at $15.01 ($62,585)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lorrain Daniel S. · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-02 | Sale : show line 1 in the form 10b5-1 | −4,170 | $15.01 | $62,585 | 151,882 | D |
| Open-market sales · 4,170 sh · avg $15.01 · $62,585 | ||||||
Loading xslF345X05/rdgdoc.xml…